Author | Kenneth A. Getz


Pharmaceutical Executive

Tracking Trial Cost Drivers: The Impact of Comparator Drugs and Co-Therapies

New research from the Tufts Center for the Study of Drug Development identifies a significant contributor to the rising cost of clinical trials-the first step in meeting a growing strategic imperative to help senior management and the regulatory community craft new approaches to make trials more efficient in delivering results to clinicians and patients.

Pharmaceutical Executive

Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist?

Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.